Expert Radar
Dr. Biree Andemariam, MD
Dr. Biree Andemariam, MD
Associate Professor, University of Connecticut School of Medicine
Doctor of Medicine, Tufts University School of Medicine
Dr. Biree Andemariam has 14 years of experience in the field of Hematology and Oncology. She earned her BA in Molecular Biology from Princeton University and her MD from Tufts University School of Medicine. After completing her residency in Internal Medicine, She went on to complete a prestigious fellowship in Hematology and Oncology at New York Presbyterian Hospital. Today, this expert is board certified in Oncology,Hematology and specializes in Molecular Biology. She is active in her field as a member of several professional societies including the American Society of Clinical Oncology,the American Society of Hematology, and the Sickle Cell Disease Association of America. She also contributes to research in her field as the author of 30 peer-reviewed journal publications and 2 books and book chapters. Formerly, this expert held roles as an Assistant Professor in the department of Medicine at UConn Health. Currently, She serves as the Chief Medical Officer at Sickle Cell Disease Association of America and as an Associate Professor in the department of Hematology and Oncology at the University of Connecticut School of Medicine.
a*********@****.edu
(800) ***-****
West Hartford, Connecticut
Get a FREE Demo of Dr. Biree Andemariam, MD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
32
Media & News
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|
Unlock Dr. Biree Andemariam, MD's full profile
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 32 records
Title | Type |
|---|---|
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura | Journal Article |
Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality | Journal Article |
Serious Adverse Events in African-American Cancer Patients with Sickle Cell Trait and Inherited Haemoglobinopathies in a SEER-Medicare Claims cohort | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Education
Institution | Degree Type |
|---|---|
Tufts University School of Medicine | Doctor of Medicine |
Princeton University | Bachelor of Arts |
Work History
Title | Employer |
|---|---|
Associate Professor | University of Connecticut School of Medicine |
Chief Medical Officer | Sickle Cell Disease Association of America Inc |
Director | Connecticut Bleeding Disorders Center |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
